Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial Written By Deeksha Bhandari21 March 2026 9:00 AM ISTThe SURMOUNT-1 trial evaluated Tirzepatide a dual GIP/GLP1 agonist, in individuals with overweight (BMI more than or equal to 27 with a comorbidity)...
SURPASS-2- Tirzepatide vs Semaglutide in Type 2 Diabetes Written By Deeksha Bhandari4 Feb 2026 12:30 PM ISTKey Summary: In addition to meeting the primary objective of noninferiority to semaglutide in type 2 diabetes (T2D), tirzepatide, at a dose of...
SURPASS-2: Superior HbA1c and Weight Reduction With Tirzepatide vs. Semaglutide Written By Deeksha Bhandari29 Jan 2026 11:00 AM ISTThe SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already...
Reassure Study: The Real-World Evidence Initiative in Recurrent early pregnancy loss Written By Deeksha Bhandari18 Dec 2025 12:00 PM ISTRecurrent early pregnancy loss (REPL) has long been marked by uncertainty, limited evidence, and treatments that offered hope without proven...
Real-World Outcomes of Dydrogesterone ER 20 mg in Recurrent Pregnancy Loss Written By Deeksha Bhandari11 Dec 2025 12:20 PM ISTRecurrent Pregnancy Loss (RPL) Burden in India Recurrent pregnancy loss (RPL) is defined as two or more consecutive pregnancy losses before 20...
Early Addition of Trimetazidine to First-Line Standard of Care Rapidly Improves Symptoms and Quality of Life in Recently Diagnosed Stable Angina Patients: The COMBINE- Angina Study Written By Deeksha Bhandari3 Dec 2025 12:15 PM ISTThe COMBINE Angina study results were presented at the ESC Congress 2025 held in Madrid, Spain. The study aimed to evaluate the benefits of early...
Ajanta Pharma Sets Worldwide Record for CPR Pledges Written By Deeksha Bhandari9 May 2025 5:22 PM ISTAjanta Pharma has achieved a significant milestone by entering the Worldwide Book of Records for organizing the maximum number of pledges to train and...
Lupin Launches Ajaduo M Forte, a Triple Fixed-Dose Combination of Empagliflozin, Linagliptin, and Metformin Extended Release (ER) Written By Deeksha Bhandari31 March 2025 10:15 AM ISTGlobal pharmaceutical company Lupin Limited has announced the launch of Ajaduo M Forte, a novel triple fixed-dose combination (FDC) therapy for the...
Post hoc Analysis: Use of Bisoprolol in NOCAD Written By Deeksha Bhandari24 Jan 2025 11:51 AM ISTBisoprolol is clinically feasible option in reducing resting heart rate (RHR) and improving left ventricular ejection fraction (LVEF), thereby...
